1. 18F-FDG PET/CT in the Hyperparathyroidism-Jaw-Tumor Syndrome
- Author
-
Birgit Pernthaler, Kinga Szurian, Tina Nazerani Hooshmand, Reingard Aigner, and Mauro Pau
- Subjects
Adenoma ,Adult ,medicine.medical_specialty ,Computed tomography ,Fibroma ,Malignancy ,Right maxilla ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Fluorodeoxyglucose F18 ,Positron Emission Tomography Computed Tomography ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,medicine.diagnostic_test ,business.industry ,Hyperparathyroidism ,General Medicine ,medicine.disease ,Jaw Neoplasms ,Hyperparathyroidism-Jaw Tumor Syndrome ,stomatognathic diseases ,Positron emission tomography ,030220 oncology & carcinogenesis ,Fdg pet ct ,Female ,Radiology ,business ,Primary hyperparathyroidism - Abstract
Hyperparathyroidism-jaw-tumor syndrome (HPT-JTS) is a rare autosomal dominant disorder. A typical manifestation of HPT-JTS is the association of jaw-ossifying fibroma with primary hyperparathyroidism. Due to its rarity and diversity in its manifestations, it is a challenging diagnosis. A 33-year-old woman was referred due to painful swelling of the right maxilla suggestive of malignancy. The clinical presentations were not conclusive until she underwent F18-fluorodeoxyglucose positron emission tomography/computed tomography (F18-FDG PET/CT). F18-FDG PET/CT proved to be a useful tool to assist the clinicians in visualizing the "bigger picture" and, therefore all manifestation as pieces of "one puzzle."
- Published
- 2021